| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | NVCR Novocure Ltd | Leonard Frank X76 | President, Cns Cancers Us | Sell | 1,684 | $76.36 | $128,594.28 | -2.6% | -6.9% | -79.9% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Watkin Jared54 | Senior Vice President | Sell | 1,198 | $100.70 | $120,638.60 | -1.7% | +0.9% | +17.7% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Earnhardt Lisa D | Executive Vice President | Sell | 943 | $100.70 | $94,960.10 | -1.2% | +0.9% | +17.7% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Dale Michael D | Senior Vice President | Sell | 1,209 | $100.70 | $121,746.30 | -2.6% | +0.9% | +17.7% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Tyler Julie L. | Senior Vice President | Sell | 525 | $100.70 | $52,867.50 | -1.3% | +0.9% | +17.7% | |
| Mar 1, 2023 | NVCR Novocure Ltd | Burke William Patrick62 | Chief Human Resources Officer | Sell | 755 | $76.36 | $57,653.61 | -1.1% | -6.9% | -79.9% | |
| Mar 1, 2023 | NVCR Novocure Ltd | Cordova Ashley75 | Chief Financial Officer | Sell | 2,198 | $76.36 | $167,844.56 | -2.2% | -6.9% | -79.9% | |
| Mar 1, 2023 | PODD Insulet Corp | Petrovic Shacey56 | Advisor | Sell | 15,000 | $276.63 | $4,149,450.00 | -20.5% | -3.5% | -41.9% | |
| Mar 1, 2023 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 1,253 | $228.47 | $286,272.91 | -39.1% | +35.1% | +69.6% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Manning Joseph J52 | Executive Vice President | Sell | 1,339 | $100.70 | $134,837.30 | -2.1% | +0.9% | +17.7% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Ahlberg Gregory A59 | Senior Vice President | Sell | 1,317 | $100.70 | $132,621.90 | -3.3% | +0.9% | +17.7% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Wainer Andrea F70 | Executive Vice President | Sell | 679 | $100.70 | $68,375.30 | -1.0% | +0.9% | +17.7% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Moreland Mary K56 | Executive Vice President | Sell | 717 | $100.77 | $72,252.09 | -0.8% | +0.9% | +17.7% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Woodgrift Randel William58 | Senior Vice President | Sell | 1,032 | $100.70 | $103,922.40 | -1.9% | +0.9% | +17.7% | |
| Mar 1, 2023 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | Director | Sell | 50,000 | $21.49 | $1,074,716.88 | -2.5% | +24.7% | -36.2% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Allen Hubert L53 | Executive Vice President | Sell | 1,069 | $100.70 | $107,648.30 | -0.6% | +0.9% | +17.7% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Ginascol John F | Executive Vice President | Sell | 943 | $100.70 | $94,960.10 | -0.8% | +0.9% | +17.7% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Salvadori Daniel Gesua Sive64 | Executive Vice President | Sell | 1,085 | $100.70 | $109,259.50 | -0.9% | +0.9% | +17.7% | |
| Mar 1, 2023 | NVCR Novocure Ltd | Shah Pritesh75 | Chief Growth Officer | Sell | 1,923 | $76.36 | $146,844.90 | -1.9% | -6.9% | -79.9% | |
| Mar 1, 2023 | ABT Abbott Laboratories | Funck, Jr. Robert E. | Executive Vice President | Sell | 1,264 | $100.70 | $127,284.80 | -0.6% | +0.9% | +17.7% | |
| Mar 1, 2023 | NVCR Novocure Ltd | Groenhuysen Wilhelmus Cm65 | Chief Operating Officer | Sell | 2,164 | $76.36 | $165,248.23 | -1.2% | -6.9% | -79.9% | |
| Mar 1, 2023 | ATEC Alphatec Holdings, Inc. | Hunsaker Craig E61 | EVP, People/ Culture &GC | Sell | 126,033 | $15.56 | $1,960,741.76 | -2.9% | -1.7% | -11.0% | |
| Mar 1, 2023 | TMCI Treace Medical Concepts, Inc. | Mott Richard W81 | Director | Sell | 50,000 | $21.35 | $1,067,545.00 | -4.3% | +24.7% | -36.2% | |
| Feb 28, 2023 | SIBN Si-Bone, Inc. | Francis Laura70 | Chief Executive Officer | Sell | 35,000 | $20.23 | $708,172.50 | -7.2% | +25.9% | -12.3% | |
| Feb 28, 2023 | AVTR Avantor, Inc. | Couturier Christophe75 | EVP, Amea | Sell | 2,324 | $24.32 | $56,519.68 | -2.3% | -15.6% | +0.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.